Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Management of Elevated Albumin-Creatinine Ratio (ACR)

Initial Assessment and Confirmation

  • The American Diabetes Association recommends confirming the elevated ACR by obtaining 2-3 specimens within a 3-6 month period, as there is high biological variability (>20%) between measurements 1
  • The American Diabetes Association suggests ruling out transient causes of elevated ACR such as exercise within 24 hours, infection, fever, congestive heart failure, marked hyperglycemia, menstruation, and marked hypertension 2
  • The National Kidney Foundation recommends calculating estimated glomerular filtration rate (eGFR) using the CKD-EPI equation to assess kidney function 1
  • The International Society of Nephrology recommends evaluating for other markers of kidney damage including urine sediment abnormalities, electrolyte disorders, and structural abnormalities 3

Risk Stratification Based on ACR Categories

  • The American Diabetes Association defines A1 (Normal to mildly increased) as ACR <30 mg/g creatinine 4
  • The American Diabetes Association defines A2 (Moderately increased) as ACR 30-300 mg/g creatinine (formerly called microalbuminuria) 4
  • The American Diabetes Association defines A3 (Severely increased) as ACR >300 mg/g creatinine 4

Management Based on ACR Category and eGFR

  • The American Heart Association recommends initiating an ACE inhibitor or angiotensin receptor blocker (ARB) for patients with hypertension and ACR 30-300 mg/g (A2 category) 2
  • The American College of Cardiology recommends monitoring serum creatinine and potassium levels periodically when using ACE inhibitors, ARBs, or diuretics 2
  • The American Heart Association suggests optimizing blood pressure control with target based on individual risk factors 5
  • The Academy of Nutrition and Dietetics recommends implementing lifestyle modifications including dietary sodium restriction, weight management, and physical activity 5

Monitoring Frequency Based on Risk

  • The National Kidney Foundation recommends that the frequency of monitoring should be guided by the combined assessment of GFR and albuminuria categories 5
  • The American Journal of Kidney Diseases recommends annual monitoring for patients with normal or mildly decreased eGFR and normal ACR 6
  • The American Journal of Kidney Diseases recommends monitoring every 6 months for patients with moderately increased ACR (30-300 mg/g) 6
  • The American Journal of Kidney Diseases recommends monitoring every 3-6 months for patients with severely increased ACR (>300 mg/g) 6

Criteria for Nephrology Referral

  • The American Diabetes Association recommends referral to nephrology for patients with eGFR <30 ml/min/1.73m² 2
  • The International Society of Nephrology recommends referral to nephrology for patients with uncertainty about the etiology of kidney disease 2
  • The American Journal of Kidney Diseases recommends referral to nephrology for patients with rapidly progressing kidney disease (change in eGFR >20% on subsequent testing) 6

Special Considerations

  • The American Diabetes Association recommends annual ACR screening for patients with diabetes, regardless of eGFR 2
  • The National Kidney Foundation recommends considering measuring cystatin C to confirm CKD diagnosis for patients with eGFR 45-59 ml/min/1.73m² without other markers of kidney damage 5
  • The American Journal of Kidney Diseases recommends evaluation for patients with a doubling of ACR on subsequent testing 6

Long-term Management

  • The American Heart Association recommends regular assessment of CKD progression risk factors including cause of CKD, level of GFR, level of albuminuria, age, sex, race/ethnicity, BP, hyperglycemia, dyslipidemia, smoking, obesity, history of cardiovascular disease, and exposure to nephrotoxic agents 5
  • The Academy of Nutrition and Dietetics recommends implementing appropriate interventions for modifiable risk factors 5
  • The American Journal of Kidney Diseases recommends considering using kidney failure risk prediction tools to guide decisions about timing of preparation for kidney replacement therapy 6